Patent Assignment
Reel/Frame 022537/0360
Assignment of Assignor's Interest
Recorded: 2009-04-13
Pages: 6
Assignor
PDL BIOPHARMA, INC.
Executed: 2009-03-09
Assignee
FACET BIOTECH CORPORATION
1500 SEAPORT BLVD., REDWOOD CITY, CALIFORNIA, 94063
Covered Properties
(4)
Stable liquid pharmaceutical formulation of IgG antibodies
Application:
10/291,528 →
Publication:
US 2003/0138417
Stable Lyophilized Pharmaceutical Formulation of Igg Antibodies
Alteration of Fc-Fusion Protein Serum Half-Lives by Mutagenesis
Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodies
Application:
11/805,971 →
Publication:
US 2008/0260730
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Mar 27, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017370/0001 →
Assignment of Assignor's Interest
Apr 5, 2006
From: KAISHEVA, ELIZABET A.; GUPTA, SUPRIYA; DUVUR, SHANTI G.; SUBRAMANIAN, MALATHY
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 017427/0209 →
Change of Name
Apr 7, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017439/0502 →
Change of Name
Dec 7, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025445/0807 →
Change of Name
Feb 18, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 029825/0070 →
Change of Name
Jul 17, 2018
From: ABBOTT BIOTHERAPEUTICS CORP.
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 046373/0957 →